This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Innovations of Juan Ignacio Oguiza
Introduction
Juan Ignacio Oguiza is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmacology, particularly in enhancing drug responses. His work focuses on the interaction of various medications and their effects on neurotransmitter availability.
Latest Patents
Oguiza holds a patent titled "Potentiation of drug response." This patent explores how the power of citalopram, fluvoxamine, and paroxetine can be augmented by administering them in combination with a drug that acts as a serotonin 1A receptor antagonist. This innovative approach aims to increase the availability of serotonin, norepinephrine, and dopamine, particularly enhancing serotonin levels.
Career Highlights
Juan Ignacio Oguiza is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly focuses on developing new therapeutic strategies to improve patient outcomes through innovative drug formulations.
Collaborations
Oguiza collaborates with David T. Wong, a respected figure in the field of pharmacology. Their partnership aims to advance research in drug interactions and therapeutic efficacy.
Conclusion
Juan Ignacio Oguiza's contributions to pharmacology through his patent and work at Eli Lilly highlight the importance of innovation in enhancing drug responses. His research continues to pave the way for improved therapeutic strategies in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile